Lena Biosciences (United States)

Recent papers from Lena Biosciences (United States)

1. Introduction to the 3RsC's cross-platform microphysiological systems evaluation for drug-induced liver injury in collaboration with FDA-CDERRegulatory Toxicology and Pharmacology · 2026
2. The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder ResponsibilitiesAlternatives to Laboratory Animals · 2025
3. Validation of a 3D perfused cell culture platform as a tool for humanised preclinical drug testing in breast cancer using established cell lines and patient-derived tissuesPLoS ONE · 2023
4. A 3D Cell Culture Organ-on-a-Chip Platform With a Breathable Hemoglobin Analogue Augments and Extends Primary Human Hepatocyte Functions in vitroFrontiers in Molecular Biosciences · 2020
5. A Device for Long-Term Perfusion, Imaging, and Electrical Interfacing of Brain Tissue In vitroFrontiers in Neuroscience · 2016
6. A basic/hydrophobic cleft of the T4 activator MotA interacts with the C‐terminus of E. coli σ70 to activate middle gene transcriptionMolecular Microbiology · 2008